Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pseudomembranous colitis].

D Bergmann1, J Koten, Z Benes

  • 1II. interní klinika Fakultní Thomayerovy nemocnice s poliklinikou, Praha. david.bergmann@ftn.cz

Vnitrni Lekarstvi
|December 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fungal communities in soils under global change.

Studies in mycology·2023
Same author

Durable Complete Response of Colorectal Cancer Metastasis after Biochemotherapy.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2017
Same author

[Insufficient use of anticoagulants in geriatric in-patients with atrial fibrillation and flutter].

Deutsche medizinische Wochenschrift (1946)·2015
Same author

[Insufficient use of anticoagulants in geriatric in-patients with atrial fibrillation and flutter (corrected)].

Deutsche medizinische Wochenschrift (1946)·2015
Same author

[The new blood test bio-marker SEPT9 and colorectal carcinoma screening].

Vnitrni lekarstvi·2013
Same author

[Examination of lymph nodes in resected colon segments with colorectal carcinoma].

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2013
Same journal

Pharmacological profile of mepolizumab.

Vnitrni lekarstvi·2023
Same journal

Atypical form of Goodpasture's disease.

Vnitrni lekarstvi·2023
Same journal

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Vnitrni lekarstvi·2023
Same journal

Dyslipidemia - the known unknown.

Vnitrni lekarstvi·2023
Same journal

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Vnitrni lekarstvi·2023
Same journal

Implications of highly suppressive treatment HIV infection.

Vnitrni lekarstvi·2023
See all related articles

Clostridium difficile-Associated Disease (CDAD) is a serious condition often caused by antibiotics. Early diagnosis and targeted treatments are crucial for effective C. difficile infection management and reducing recurrence.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Microbiology

Context:

  • Pathologic proliferation of toxigenic Clostridium difficile causes colonic inflammation, manifesting as pseudomembranous colitis.
  • Clostridium difficile-Associated Disease (CDAD) incidence has risen due to highly virulent strains like ribotype 027.
  • Antibiotic use is a primary trigger, but other pathogenetic factors also contribute to CDAD.

Purpose:

  • To review the pathogenesis, diagnosis, and treatment of Clostridium difficile-Associated Disease (CDAD).
  • To highlight the increasing significance of virulent C. difficile strains and epidemic potential.
  • To emphasize the importance of timely diagnosis and effective therapeutic strategies for CDAD.

Summary:

  • CDAD, or Clostridium difficile-Associated Disease, is a significant cause of antibiotic-associated diarrhea and colitis.

Related Experiment Videos

  • Diagnosis relies on stool toxin testing and endoscopy, with targeted antibiotics like metronidazole and vancomycin being key treatments.
  • Despite effective treatments, CDAD recurrence rates can reach 25%, necessitating ongoing research and surveillance.

    • Impact:

    • Effective management of CDAD requires prompt diagnosis and appropriate antibiotic therapy.
    • The emergence of hypervirulent C. difficile strains necessitates enhanced surveillance and reference laboratory capabilities.
    • Understanding CDAD's multifactorial nature is vital for preventing severe outcomes and controlling outbreaks.